Assuntos
Naltrexona/análogos & derivados , Antagonistas de Entorpecentes/urina , Entorpecentes/urina , Oximorfona/urina , Detecção do Abuso de Substâncias/métodos , Dopagem Esportivo , Estabilidade de Medicamentos , Cromatografia Gasosa-Espectrometria de Massas/métodos , Humanos , Naltrexona/química , Naltrexona/urina , Antagonistas de Entorpecentes/química , Entorpecentes/análise , Oximorfona/análise , Compostos de Amônio Quaternário/química , Compostos de Amônio Quaternário/urinaRESUMO
To free analytical resources for new classes of doping substances, such as banned proteins, maximization of the number of compounds that can be determined with high sensitivity in a single run is highly urgent. This study demonstrates an application of 'wrong-way-round ionization' for the simultaneous detection of multiple classes of doping substances without the need to switch the polarity. A screening method for the detection of 137 compounds from various classes of prohibited substances (stimulants, diuretics, ß(2)-agonists, ß-blockers, antiestrogens, glucocorticosteroids and anabolic agents) has been developed. The method involves an enzymatic hydrolysis, liquid-liquid extraction and detection by liquid chromatography/orbitrap mass spectrometry with wrong-way-round ionization. Up to 64% of compounds had a 10-fold lower limit of detection (LOD) than the minimum required performance limit. To compare the efficiency of conventional ionization relative to wrong-way-round ionization of doping substances in + ESI, a fortified blank urine sample at the minimum required performance limit was analyzed using two ESI approaches. All compounds were detected with markedly better S/N in a high-pH mobile phase, with the exception of acetazolamide (minimal change in S/N, < 20%).The method was validated by spiking 10 different blank urine samples at five different concentrations. Validation parameters included the LOD, selectivity, ion suppression, extraction recovery and repeatability.
Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Dopagem Esportivo , Preparações Farmacêuticas/urina , Espectrometria de Massas em Tandem/métodos , Antagonistas Adrenérgicos beta/urina , Anabolizantes/urina , Diuréticos/urina , Glucocorticoides/urina , Humanos , Limite de Detecção , Extração Líquido-Líquido , Preparações Farmacêuticas/química , Reprodutibilidade dos TestesRESUMO
A new doping control screening method has been developed, for the analysis of doping agents in human urine, using HPLC/orbitrap with in-source collision-induced dissociation and atmospheric pressure chemical ionization. The developed method allows the detection of 29 compounds, including agents with antiestrogenic activity, beta(2) agonists, exogenous anabolic steroids, and other anabolic agents. The mass accuracy of this method is better at 2 ppm using an external reference. The detection limit for all compounds tested was better than 100 pg/ml. The recoveries of most analytes were above 70%. The measured median repeatability values for doping agents included in the method at concentrations of 1 and 10 ng/ml were 21 and 17%, respectively. The relative standard deviation (RSD) of the intraday precision (n = 6) ranged from RSD = 16-22%, whereas the interday precision (n = 18), ranged from RSD = 17-26%, depending on the solute concentration investigated.
